Medotech continues to sponsor clinical studies around the world in order to provide further evidence of the efficacy and safety of the new device. Currently clinical studies are in progress at the Danish Head Ache Center at Glostrup Hospital in Copenhagen represented by Professor Rigmor Jensen and at the Dental School at the University of Aarhus, Denmark represented by Professor Peter Svensson. The studies focus on tension type headache and temporomandibular disorders (TMD) characterized by pain and tension in facial muscles and joints.
Medotech launched Grindcare 3.0 at the world's biggest dental fair, IDS, in Cologne from 24 -28 March this year and started distribution in more than 9 European countries. Medotech expects to launch it in the US in 2010.
Source-Medindia
GPL